Construction of Peptide Library in Mammalian Cells by dsDNA-Based Strategy

While different display technologies, represented by phage display, have been widely used in drug discovery, they still can hardly achieve function-based peptide screening, which in most cases is performed in mammalian cells. And most attempts to screen functional peptides with mammalian platforms utilized plasmids to store coding information. Our previous work established double-stranded DNAs (dsDNAs) as innovative biological parts to implement AND-gate genetic circuits in mammalian cells. In the current study, we employ dsDNAs with terminal NNK degenerate codons to implement AND-gate genetic circuits and generate peptide libraries in mammalian cells. This dsDNA-based AND-gate (DBAG) peptide library construction strategy is easy to perform, requiring only PCR reaction and cell transfection. High-throughput sequencing (HTS) and single-cell sequencing results revealed both peptide length and amino acid sequence diversity of DBAG peptide libraries. Moreover, as a feasibility test of this strategy, we identified an MDM2-interacting peptide by applying the DBAG peptide library to a mammalian cell-based two-hybrid system. Our work establishes dsDNAs with terminal degenerate codons as biological parts to build peptide libraries in mammalian cells, which may have great application potential in the future.

[1]  N. Li,et al.  High-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidics , 2021, Science Advances.

[2]  Chunze Zhang,et al.  Linear double‐stranded DNAs as innovative biological parts to implement genetic circuits in mammalian cells , 2019, The FEBS journal.

[3]  I. V. Chernikov,et al.  Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma , 2018, Science Advances.

[4]  Ruth Suchsland,et al.  Preparation of trinucleotide phosphoramidites as synthons for the synthesis of gene libraries , 2018, Beilstein journal of organic chemistry.

[5]  R. Lerner,et al.  Replacing reprogramming factors with antibodies selected from combinatorial antibody libraries , 2017, Nature Biotechnology.

[6]  Ali Tavassoli,et al.  SICLOPPS cyclic peptide libraries in drug discovery. , 2017, Current opinion in chemical biology.

[7]  A. Tavassoli,et al.  Reprogramming the Transcriptional Response to Hypoxia with a Chromosomally Encoded Cyclic Peptide HIF-1 Inhibitor , 2016, ACS synthetic biology.

[8]  T. Blundell,et al.  Different DNA End Configurations Dictate Which NHEJ Components Are Most Important for Joining Efficiency* , 2016, The Journal of Biological Chemistry.

[9]  R. Lerner,et al.  Autocrine-Based Selection of Drugs That Target Ion Channels from Combinatorial Venom Peptide Libraries. , 2016, Angewandte Chemie.

[10]  Neville E Sanjana,et al.  Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening , 2016, Nature Protocols.

[11]  S. Reddy,et al.  Transpo-mAb display: Transposition-mediated B cell display and functional screening of full-length IgG antibody libraries , 2016, mAbs.

[12]  R. Lerner,et al.  Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects , 2015, Nature Communications.

[13]  R. Lerner,et al.  A proximity based general method for identification of ligand and receptor interactions in living cells. , 2014, Biochemical and biophysical research communications.

[14]  M. Tyers,et al.  Targeting the INCENP IN-box–Aurora B interaction to inhibit CPC activity in vivo , 2014, Open Biology.

[15]  N. Kobayashi,et al.  Structural Basis for Inhibition of the MDM2:p53 Interaction by an Optimized MDM2-Binding Peptide Selected with mRNA Display , 2014, PloS one.

[16]  A. Tavassoli,et al.  Peptides come round: using SICLOPPS libraries for early stage drug discovery. , 2014, Chemistry.

[17]  R. Lerner,et al.  Selecting agonists from single cells infected with combinatorial antibody libraries. , 2013, Chemistry & biology.

[18]  R. Lerner,et al.  Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cells , 2013, Proceedings of the National Academy of Sciences.

[19]  H. Fritz,et al.  A new and convenient approach for the preparation of β-cyanoethyl protected trinucleotide phosphoramidites. , 2012, Organic & biomolecular chemistry.

[20]  P. Bowers,et al.  Coupling mammalian cell surface display with somatic hypermutation for the discovery and maturation of human antibodies , 2011, Proceedings of the National Academy of Sciences.

[21]  N. Doi,et al.  mRNA Display Selection of an Optimized MDM2-Binding Peptide That Potently Inhibits MDM2-p53 Interaction , 2011, PloS one.

[22]  Chong Li,et al.  Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX , 2009, Proceedings of the National Academy of Sciences.

[23]  M. Bachmann,et al.  Isolation of human monoclonal antibodies by mammalian cell display , 2008, Proceedings of the National Academy of Sciences.

[24]  Elias A. Rahal,et al.  ATM mediates repression of DNA end-degradation in an ATP-dependent manner. , 2008, DNA repair.

[25]  Mitchell Ho,et al.  Isolation of anti-CD22 Fv with high affinity by Fv display on human cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Payan,et al.  Retrovirally Delivered Random Cyclic Peptide Libraries Yield Inhibitors of Interleukin-4 Signaling in Human B Cells* , 2002, The Journal of Biological Chemistry.

[27]  F. Alt,et al.  The Mechanism and Regulation of Chromosomal V(D)J Recombination , 2002, Cell.

[28]  D. Schatz.  V(D)J recombination , 2002, Immunological reviews.

[29]  Anthony D. Keefe,et al.  Constructing high complexity synthetic libraries of long ORFs using in vitro selection. , 2000, Journal of molecular biology.

[30]  S. Benkovic,et al.  Production of cyclic peptides and proteins in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J W Szostak,et al.  RNA-peptide fusions for the in vitro selection of peptides and proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Eric T. Boder,et al.  Yeast surface display for screening combinatorial polypeptide libraries , 1997, Nature Biotechnology.

[33]  A. Plückthun,et al.  In vitro selection and evolution of functional proteins by using ribosome display. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Levine,et al.  Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.

[35]  W. Dower,et al.  An in vitro polysome display system for identifying ligands from very large peptide libraries. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  E. Fearon,et al.  Karyoplasmic interaction selection strategy: a general strategy to detect protein-protein interactions in mammalian cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Scott,et al.  Searching for peptide ligands with an epitope library. , 1990, Science.

[38]  G. P. Smith,et al.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.

[39]  Stephen J Benkovic,et al.  Split-intein mediated circular ligation used in the synthesis of cyclic peptide libraries in E. coli , 2007, Nature Protocols.

[40]  Christos Stathopoulos,et al.  Display of heterologous proteins on the surface of microorganisms: From the screening of combinatorial libraries to live recombinant vaccines , 1997, Nature Biotechnology.